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Tart cherries, vascular and cognitive function 
Keywords:  Tart cherries, cerebral blood flow, blood pressure, cognitive performance 
Abstract 1 
Cerebral blood volume and metabolism of oxygen declines as part of human ageing and this has been 2 
previously shown to be related to cognitive decline.  There is some evidence to suggest that 3 
polyphenol-rich foods can play an important role in delaying the onset or halting the progression of 4 
age-related health disorders such as cardiovascular and Alzheimer’s disease, and to improve cognitive 5 
function.  In the present study, an acute, placebo-controlled, double blinded, cross-over, randomised 6 
Latin square design study with a wash-out period of at least 14 days was conducted in twenty-seven 7 
middle aged (defined as 45-60 years) volunteers. Participants received either a 60 mL dose of a 8 
Montmorency tart cherry concentrate (MC), which contains 68.0 ±0.26 mg cyanidin-3-glucoside /L, 9 
160.75 ± 0.55 mean gallic acid equiv/L and 0.59 ± 0.02 mean Trolox equiv/L, respectively or a 10 
placebo (PLA).  Cerebrovascular responses, cognitive performance and blood pressure were assessed 11 
at baseline and 1, 2, 3 and 5 h following consumption.  There were significant differences in 12 
concentrations of total and oxy-haemoglobin during the task period 1 h post MC consumption (p ≤ 13 
0.05).  Furthermore, MC consumption significantly lowered SBP (p ≤ 0.05) over a period of 3 h, with 14 
peak reductions of 6 ± 2 mmHg at 1 h post MC consumption relative to the placebo.  Cognitive 15 
function and mood were not affected.  These results show that a single dose of MC concentrate can 16 
modulate certain variables of vascular function; however this does not translate to improvements in 17 
cognition or mood. 18 
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 30 
Tart Montmorency cherries modulate vascular function acutely, in the absence of improvement 31 
in cognitive function 32 
Introduction  33 
Montmorency tart cherries (L. Prunus Cerasus) and their derivatives are a functional food that are 34 
high in numerous phytochemicals 
(1; 2; 3; 4; 5)
 that include the flavonoids isorhamnetin, kaempferol, 35 
quercetin, catechin, epicatechin, procyanidins, and anthocyanins 
(6; 7)
. It has been previously shown 36 
that Montmorency tart cherries attenuate inflammation 
(1)
, oxidative stress 
(8; 9)
 and improve aspects of 37 
vascular function 
(3)
.  One property underlying the potential vascular effects of tart cherries is an 38 
ability to modulate blood flow parameters.  Cherry extracts have been shown, in cell and animal 39 
models, to exert a range of cardio-protective effects that include increasing nitric oxide production 40 
and antioxidant status, reducing lipid oxidation and inhibiting inflammatory pathways 
(1; 4)
.  Even 41 
more recently, Keane et al. 
(3)
 demonstrated an increase in plasma phenolic acids (vanillic and 42 
protocatechuic) following Montmorency tart cherry consumption in humans; these compounds were 43 
also shown to modulate vascular smooth muscle cell behaviour in vitro.  In a subsequent study, Keane 44 
and colleagues demonstrated that circulating phenolic metabolites derived from Montmorency tart 45 
cherry juice are, at least in part, responsible for an acute reduction in systolic blood pressure in men 46 
with early hypertension 
(10)
. 47 
Aging is associated with deficits in motor function, which include decreases in balance, muscle 48 
strength, coordination, and cognitive function, especially in tasks that require the use of spatial 49 
learning and memory. This has been suggested to be caused by a concurrent decline in cerebral blood 50 
volume and metabolism of oxygen which also occurs as a result of aging 
(11)
.  These decrements have 51 
been reported in numerous studies in both animals 
(12; 13)
 and humans 
(14; 15)
.  A large number of dietary 52 
interventions using polyphenol-rich foods or beverages, in particular those using tea 
(16)
, Gingko 53 
Biloba 
(17)
, cocoa 
(18)
 and blueberry 
(19)
, have demonstrated beneficial effects on memory and learning 54 
in both animals and humans.  Although it is not clear whether tart cherries can decrease the risk of 55 
neurodegenerative aging or diseases such as Parkinson’s and Alzheimer in humans, studies with 56 
animal models are more positive and suggest that the phenolic compounds found in tart cherries, may 57 
exert their beneficial effects through their ability to lower oxidative stress and anti-inflammatory 58 
properties or by altering directly the signalling involved in neuronal communication, calcium 59 
buffering ability, stress signalling pathways among others 
(19; 20)
.  60 
Seymour et al 
(21)
 showed that intake of 1% tart cherry diet significantly reduced stroke-related 61 
phenotypes in rats. Tart cherry intake also reduced brain NFκB activity and the related pro-62 
inflammatory transcripts.  Interestingly in 2015, Kirakosyan and colleagues 
(22)
 confirmed that tart 63 
cherry anthocyanins cross the blood-brain barrier.  In a more recent addition to the literature, thirty 64 
19-month-old male Fischer 344 rats who received either a control diet or a diet supplemented with 2% 65 
Montmorency tart cherry for six weeks were examined.  Results showed that although there were no 66 
changes on motor performance, tart cherry supplementation significantly improved working memory 67 
of aged rats 
(23)
.  However, there is a paucity of data from human trials to extrapolate these findings to 68 
hominids.   69 
Caldwell et al., 
(24)
 previously demonstrated that regardless of dose, cherry juice had no acute impact 70 
on cognitive function in young people, older people or dementia patients.  They concluded that 71 
although cherry juice may have an acute impact on cardiovascular function, there was no change in 72 
cognitive performance 6 h post consumption.  Contrastingly, a chronic supplementation study 
(25)
 73 
reported that the daily consumption of sweet cherries for 12 weeks improved cognitive performance 74 
across almost all tasks in older adults with mild-to-moderate dementia; this group showed 75 
improvements for category verbal fluency and tasks relating to verbal learning and memory and 76 
concluded the positive changes have clinical relevance for these cognitive improvements.  It would 77 
therefore appear that the cerebrovascular response required to elicit measurable changes in cognitive 78 
function can only be achieved with longer term dosing strategies 
(26)
. Contrary to this theory, two 79 
recent additions to the literature suggest that acute supplementation has the ability to improve aspects 80 
of cognitive function.  Acute blackcurrant supplementation was shown to improve both digit vigilance 81 
and rapid visual information processing in healthy younger humans 
(27)
.  Similarly, acute wild 82 
blueberry supplementation was shown to improve final immediate recall, delayed word recognition, 83 
and accuracy on cognitively demanding incongruent trials in the interference task in in children 
(28)
.  84 
Therefore, it is possible that Caldwell and colleagues reported no impact of cherry supplementation on 85 
cognitive function as they used sweet cherries as an intervention.  It has previously been speculated 86 
that sweet cherries are not as rich in phytochemical compounds as tart cherries
(6)
.    87 
Polyphenol-rich foods have also been reported to improve cerebral haemodynamics assessed by near 88 
infrared spectroscopy (NIRS) and function magnetic resonance imaging (fMRI). Wightman and 89 
colleagues 
(29)
 assessed the effect of EGCG on cerebral blood flow using NIRS in healthy adults.  90 
Results suggested that 135 mg of EGCG caused a reduction in total haemoglobin, a proxy for cerebral 91 
blood flow during cognitive tasks relative to the placebo.  Changes in cerebral blood flow has also 92 
been demonstrated following resveratrol 
(30)
 and beetroot supplementation 
(31)
.  Krikorian et al., 
(32)
 93 
used fMRI to examine the effect of Concord grape juice on neurocognitive function.  Sixteen adults 94 
aged >68 y with mild age-related memory decline were supplemented with either a grape juice (444 95 
ml average) containing on average, 209mg of polyphenols, or a sugar matched placebo for 16 weeks.  96 
Results found that after 16 weeks, there were reductions in semantic interference on memory tasks 97 
and relatively greater activation in anterior and posterior regions of the right hemisphere in the grape 98 
juice treated group. Similarly, people with mild memory complaints, who drank pomegranate juice 99 
daily, performed better on memory task compared to a placebo and displayed an increase in brain 100 
activation measured by fMRI 
(33)
. Very little has been reported on the effect of acute polyphenol 101 
supplementation on cerebral haemodynamics, with the majority of this work carried out with flavanol-102 
rich cocoa 
(34; 35)
.  At present, no attempt been made to examine the haemodynamic response to acute 103 
tart cherry supplementation. 104 
Notwithstanding, given that Montmorency tart cherries are capable of modulating human vascular 105 
function (particularly in relation to blood pressure and vascular smooth muscle behaviour), we 106 
hypothesised that cerebral blood flow could also be acutely modulated and consequently improve 107 
cognitive performance in humans.  Therefore, the aim of the present study was to assess the impact of 108 
Montmorency tart cherry juice consumption on pre-frontal cortical haemodynamics, cognitive 109 
function and blood pressure in middle aged adults. 110 
Methods 111 
Participants  112 
Thirty healthy middle aged (defined as 45-60 years) adults (10 female, 20 male, 28 right-handed, 2 113 
left-handed) were recruited to take part in the study; the mean ± SD age, stature, mass and BMI were 114 
50 ± 6 years, 170.7 ± 9.1 cm, 76.0 ± 16.0 kg and 26.1 ± 4.9 kg/m
2
, respectively.  All participants were 115 
in apparent good health as assessed by a health-screening questionnaire.  This questionnaire was 116 
administered to highlight any contraindications to taking part in the study. Exclusion criteria included 117 
those who had suffered a head injury, neurological disorder or neuro-developmental disorder. In 118 
addition, those who had any relevant food allergies or intolerances, smoked tobacco, drank excessive 119 
amounts of caffeine [>6 cups coffee/d (>450 mg caffeine/d)], or took illicit social drugs were also 120 
identified as contraindications to participation.  All exclusion criteria were self-reported.  The study 121 
was conducted in accordance with the Helsinki Declaration and ratified by the University’s Research 122 
Ethics Committee. All enrolled participants provided written informed consent. This study was 123 
registered as a clinical trial with clinicaltrials.gov (NCT02381860). 124 
Study Design 125 
This study employed a placebo-controlled, double blinded, cross-over, randomised Latin square 126 
design with two experimental arms and a washout period of at least 14 days (mean ± SD, 15 ± 2 days); 127 
participants were randomly allocated to receive a 60 mL dose of a Montmorency cherry (MC) 128 
concentrate or a placebo (PLA). Fourteen participants received the MC concentrate on the first visit, 129 
with the remainder receiving the PLA. A washout of at least 14 days was chosen based on previous 130 
literature that suggests these phenolic compounds are quickly absorbed and/or excreted 
(3; 10; 36)
.  Each 131 
participant was required to attend the laboratory on three separate occasions.  Each visit was at the 132 
same time of day (within participant) and was preceded by an overnight fast (≥10 h). The first visit 133 
was an initial screening and familiarisation visit during which, participants were screened with 134 
regards to the study exclusion/inclusion criteria, briefed with regards to compliance requirements, 135 
provided written informed consent and given full training and familiarisation on the cognitive tasks. 136 
On the subsequent experimental days, participants reported to the lab between 7 and 9am and a 137 
baseline blood pressure (BP) reading was taken.  This was followed by a baseline cognitive 138 
assessment and cerebral blood flow measures by near infrared spectroscopy (NIRS) and transcranial 139 
Doppler (TCD).  Participants then consumed the intervention beverage (either MC or PLA), following 140 
which, they sat quietly, watching one of a selection of non-arousing DVDs, during a 1 hour 141 
“absorption period”.   Subsequent cognitive assessments and blood flow measures were taken 1, 2, 3, 142 
and 5 h post consumption; BP was performed hourly.  Between cognitive test sessions, participants 143 
continued to watch a selection of non-arousing DVDs.  No additional food or fluid was provided 144 
during the study period except for low-nitrate mineral water, which was consumed ad libitum.  The 145 
total volume of water consumed on the first experimental day was recorded and participants 146 
consumed the same volume on the second visit.  The reason for this was to accurately examine the 147 
efficacy of the intervention.  Previous studies have  148 
Treatments and Dietary Control 149 
A MC concentrate (CherryActive, Sunbury, UK) was stored at 4º C prior to use.  Participants 150 
consumed either 60 mL of MC concentrate (which according to the manufacturer is estimated to be 151 
equivalent to ~180 whole cherries) or fruit-flavoured cordial in a double blind, cross-over manner.  152 
This estimate is based on the brix value of sucrose in 100 g of solution. The decision to use 60 mL 153 
was based on previous work that showed a greater uptake of anthocyanin and phenolic acids in vivo 154 
post-consumption when compared to a 30 mL dose 
(2; 3)
.  Additionally, this work identified that of the 155 
three Montmorency cherry analogue studied (frozen, dried and concentrated), the MC concentrate had 156 
the greatest antioxidant activity, total anthocyanin and phenolic content 
(3)
. The MC concentrate was 157 
examined for total anthocyanins, total phenolic content and Trolox Equivalent Antioxidant Capacity 158 
using techniques previously described by Keane and colleagues 
(10)
.  The MC concentrate was found 159 
to contain 68.0 ±0.26 mg cyanidin-3-glucoside /L, 160.75 ± 0.55 mean gallic acid equiv/L and 0.59 ± 160 
0.02 mean Trolox equiv/L, respectively.   The concentrate was diluted with 100 mL of water prior to 161 
consumption.   162 
The PLA supplement consisted of a commercially available, low fruit (<1%) cordial (Kia Ora, Coca 163 
Cola Enterprises, Uxbridge, UK) mixed with water, whey protein isolate (Arla Foods Ltd., Leeds, UK) 164 
and maltodextrin (MyProtein Ltd., Northwich, UK), to match the MC concentrate for volume and 165 
macronutrient content (Energy = 204 kcal, volume = 60 mL, carbohydrates = 49 g, protein = 2.2 g and 166 
fat = 0 g). The total anthocyanin content (used for colour purposes only) and total antioxidant capacity 167 
of the PLA were lower than the limits of detection, with trace amounts of phenolics (8.26 ± 0.04 mean 168 
gallic acid equiv/L).  All drinks were prepared and all bottles were covered in tape prior to the study 169 
by a third party.  Prior to study commencement, it was explained to participants that the aim of the 170 
study was to investigate the effect of a fruit juice on vascular function; therefore they were unaware 171 
which beverage was the experimental drink. Participants were instructed to follow a low phenolic diet 172 
for 48 h prior to each arm of the trial by avoiding fruits, vegetables, tea, coffee, alcohol, chocolate, 173 
cereals, wholemeal bread, grains and spices and were asked to refrain from strenuous exercise.  174 
Compliance with the dietary restrictions was assessed with a standardised, self-reported 2-day dietary 175 
record.  All participants complied with the low phenolic diet and this was confirmed via visual 176 
inspection of the food diaries.   177 
Cognitive Tasks 178 
All cognitive and mood measures were delivered using the Computerised Mental Performance 179 
Assessment System (COMPASS, Northumbria University, Newcastle upon Tyne, UK), a purpose-180 
designed software application for the flexible delivery of randomly generated parallel versions of 181 
standard and novel cognitive assessment tasks. This assessment system has previously been shown to 182 
be sensitive to nutritional interventions following both acute 
(37)
 including acute supplementation with 183 
phenolics 
(27)
 and chronic supplementation 
(38)
. At each of the aforementioned time points, a cognitive 184 
assessment test was completed. This assessment was a collection of three tasks that lasted 9 minutes; 185 
this was performed twice, which equated to 18 minutes in total.  This was followed by a series of 186 
visual analogue scales to assess perceptions of fatigue and difficulty.  The types of tests chosen have 187 
been previously used to detect changes in cognitive function following nutritional interventions 
(18; 27; 188 
30)
. In order to assess the relationship between specific brain regions and any changes in CBF, a 189 
selection of tasks that engender either higher or lower activation of the frontal cortex were employed. 190 
The “low activation” tasks comprised of a sustained attention test (digit vigilance).  The “high 191 
activation” tasks (Rapid Visual Information Processing and Stroop tasks) entail a higher cognitive 192 
workload and have been shown to increase activity in the pre frontal cortex 
(39; 40)
.  The battery of 193 
cognitive tasks is described in more detail below.   194 
Digit Vigilance 195 
The DV task is a measure of sustained attention and psychomotor speed 
(41)
.  A single target digit was 196 
randomly selected and constantly displayed on the right hand side of the screen.  A series of single 197 
digits appeared on the left hand side of the screen, one at a time, at the rate of 150 per minute.  The 198 
participant was required to press the target button on the response pad as quickly as possible every 199 
time the digit in the series matched the target digit.  The task lasted three minutes in total.  Task 200 
outcomes included accuracy (%) and reaction time for correct responses (ms) 201 
Rapid Visual Information Processing (RVIP) 202 
The RVIP task is a measure of sustained attention and working memory 
(41)
.  This task requires the 203 
participant to monitor a continuous series of single digits for targets of three consecutive odd or three 204 
consecutive even digits.  The digits are presented on the computer screen one at a time at the rate of 205 
100 per minute in pseudo-random order, and the participant responds to the detection of a target string 206 
by pressing the target button on the response pad as quickly as possible. The task lasted three minutes 207 
in total.  Task outcomes included number of target strings correctly detected (%) and average reaction 208 
time for correct detections (ms). 209 
Stroop 210 
The Stroop test is a measure of attention, inhibition and cognitive flexibility 
(42)
.  In this task, 211 
participants were presented with a colour name.  The colour name presented was written in a coloured 212 
font, either the same “congruent” or a different “incongruent” font.  Participants had to identify the 213 
colour of the font the word was written in, rather than the colour that the word was describing, via a 214 
response pad with coloured keys.   Participants were presented with 90 stimuli in total taking ~3 215 
minutes to complete. Task outcomes included number of correct responses (%) and the average 216 
response time for congruent and incongruent stimuli (ms).   217 
Visual Analogue Scales  218 
Participants were required to rate how “alert”, “concentrated” and ‘mentally fatigued’ they felt and 219 
how ‘difficult’ they had found the tasks after each cognitive assessment repetition by indicating on a 220 
100 mm line with the cursor (“not at all” at one end of the line and “extremely” at the other end) for 221 
alertness, fatigue and level of difficulty and (“very low” to “very high”) for concentration.  The VAS 222 
were scored as % along the line denoting more of the relevant adjective. 223 
Blood Pressure  224 
Blood pressure was measured using a non-invasive digital automatic BP monitor (M10-IT Omron 225 
Healthcare, UK).  The BP cuff was fitted by the same researcher at each of the six time points. The 226 
inter- and intra-trial %CV for this method was 4.2 and 1.3% respectively.  227 
Cerebrovascular Responses 228 
Transcranial Doppler Imaging 229 
Cerebral blood flow velocity in the middle cerebral artery (CBFV) was determined using transcranial 230 
Doppler sonography (Doppler-Box, Compumedics DWL, Singen, Germany). A 2 MHz Doppler probe 231 
was positioned over the right middle cerebral artery using previously described search techniques 
(43)
, 232 
and secured with an adjustable headset (DiaMon, Compumedics DWL). The mean depth for Doppler 233 
signals was 62 ± 3 mm. All data were sampled at 200 Hz (PowerLab 16/30, ADInstruments Ltd, 234 
Oxfordshire, UK), and processed offline (LabChart version 5.4.2, ADInstruments Ltd).   235 
Near Infrared Spectroscopy (NIRS)  236 
The NIRS is a non-invasive brain imaging technique in which two nominal wavelengths of light, 237 
which are differentially absorbed by oxygenated (oxy-Hb) and deoxygenated haemoglobin (deoxy-238 
Hb), respectively, are introduced through the skull via a laser emitter.  They are then measured, 239 
following transit through the upper surface of the cortex, by an optode placed at a pre-set distance 240 
from the light source. NIRS has been used extensively as a technique for multiple-channel imaging of 241 
task-related brain activity over relevant areas of the head, including groups suffering from potential 242 
declines in CBF 
(44)
.  In the current study, cerebral oxygenation was assessed using near-infrared 243 
spectroscopy (NIRS; NIRO-200NX, Hamamatsu Photonics K.K., Japan). Two near-infrared sensors 244 
were placed over the left and right frontal lobe region of the forehead corresponding to the 245 
International 10–20 system Fp1 and Fp2 EEG positions; these signals were averaged to determine 246 
cerebral oxygenation. The sensors were secured to the skin using double-sided adhesive tape and 247 
shielded from ambient light using an elastic bandage. The sensors alternately emit two wavelengths of 248 
near-infrared light (≈765 and 855 nm) with an emitter/optode separation distance of 4 cm. The NIRS 249 
data were acquired continuously and output every 5 s and recorded for later offline analysis.  The 250 
NIRS data output was time stamped at the start of each task segment to assure that data corresponded 251 
to the relevant period of task performance. Relative concentration changes in Oxy-Hb, Deoxy-Hb and 252 
Total-Hb were calculated.  253 
Statistical Analysis  254 
Cognitive performance, BP and CBFV data were analysed by using a treatment × time point mixed 255 
model analysis of variance (ANOVA).  Maulchy’s Test of Sphericity was used to check homogeneity 256 
of variance for all ANOVA analyses; where necessary, violations of the assumption were corrected 257 
using the Greenhouse–Geisser adjustment. Significant main effects were followed up using Šidák post 258 
hoc analysis.   The analysis of NIRS data was conducted with Minitab 15 for Windows (Minitab Inc, 259 
State College, PA).  Prior to the primary analysis, a within subjects Analysis of Variance (ANOVA) 260 
was carried out with left/right optode included as a factor (hemisphere x treatment group) for each 261 
task. As there were no treatment related interactions involving hemisphere the data from the 2 262 
channels were averaged across hemispheres for the analysis and figures reported below.  For each 263 
variable (oxy-Hb, deoxy-Hb and total Hb), data were converted to “change from baseline” (calculated 264 
from baseline pre-treatment period). Task length was fixed for the DV (180 s) and RVIP (180 s), but 265 
NIRS data from the Stroop test were truncated so that the same amount of data was analysed for all 266 
participants during each task period.  Data from the ‘resting/absorption’ period (minutes 1-60) and the 267 
task performance were analysed separately for all time points [pre–supplement, 1, 2, 3 and 5 h].  Data 268 
from the ‘resting/absorption’ period was averaged across 6 equal 10-min epochs and analysed by two 269 
– way repeated measures analysis of variance (ANOVA) (epoch × treatment).  Data from the task 270 
period data was averaged across 6 equal 3-min epochs.  This data was analysed by a three-way 271 
repeated measures ANOVA (task (epoch) × treatment × time point).   272 
In the absence of any directly relevant data, it was suggested that a sample size of twenty – four 273 
would be adequate to have greater than an 80% chance of detecting the medium effect sizes 274 
demonstrated in previous research assessing the effect of polyphenols on NIRS parameters 
(45)
.  The 275 
resultant sample size of 27 (for a within-subjects, crossover design) was in excess of the typical 276 
sample sizes for NIRS investigations. 277 
Results  278 
Thirty male and female participants volunteered to take part in the study, but three participants 279 
voluntarily withdrew after the first study day due to time constraints (n=27).  There were no adverse 280 
events reported in response to the intervention products. All participants complied with the low-281 
polyphenolic diet according to the food diaries.  282 
Cognitive performance and mood 283 
No significant treatment-related differences were observed for any of the cognitive or mood measures 284 
(p>0.05).   The absolute values for task scores and mood ratings are given in Tables 1 and 2, 285 
respectively.  286 
Blood pressure 287 
Systolic blood pressure (SBP) exhibited a time (p ≤ 0.01), and treatment × time interaction effects 288 
(p=0.002).  A post-hoc Šidák test indicated that this difference occurred at 1, 2, 3 h post 289 
supplementation in the MC group, with peak reductions from baseline in postprandial SBP of 6 ± 2 290 
mmHg at 1 h post MC consumption (Figure 1). There was no time, treatment or treatment × time 291 
interaction effects observed for diastolic blood pressure (DBP).     292 
Transcranial Doppler Imaging  293 
There was no time, treatment or treatment × time interaction effects observed for cerebral blood flow 294 
velocity (p>0.05).   295 
Near-IR spectroscopy parameters 296 
Oxygenated haemoglobin (oxy-Hb).  Similarly, there was a significant interaction between treatment 297 
and posttreatment epoch on the initial ANOVA during the resting/absorption period (p=0.029).  298 
Reference to planned comparisons showed that there were significantly higher oxy-Hb concentrations 299 
during the 30-40 min epoch of the resting/absorption period for MC concentrate.  MC concentrate 300 
also resulted in higher oxy-Hb concentrations during each epoch of task performance 1 h post 301 
consumption (p=0.019).  Thereafter, there were no significant differences in oxy-Hb (p>0.05) (Figure 302 
2A). 303 
Deoxygenated haemoglobin (deoxy – Hb). There were no significant differences in terms of deoxy-Hb 304 
during either the resting/absorption or task performance periods (p>0.05). 305 
Total haemoglobin (Total-Hb).  There was no significant interaction between treatment and 306 
posttreatment epoch on the initial ANOVA during the resting/absorption period (p > 0.05).  MC 307 
concentrate resulted in higher total-Hb concentrations during each epoch of task performance 1 h post 308 
consumption (p ≤ 0.01).  Thereafter, there were no significant differences in total-Hb (p>0.05) 309 
(Figure 2B). 310 
Task-related differences.  There were no significant differences seen in the hemodynamic response to 311 
the DV, RVIP or Stroop tasks.  312 
 313 
Discussion 314 
To the best of our knowledge, this study was the first to investigate the acute effects of Montmorency 315 
tart cherries consumption on cerebral blood flow variables and cognitive performance in a middle 316 
aged population. In support of our hypothesis, this study presents new information that in comparison 317 
to placebo, the consumption of a MC concentrate resulted in acute modulation of CBF parameters in 318 
the frontal cortex during task performance as indicated by the elevated concentration of total-Hb, with 319 
an identical pattern observed with oxy-Hb.  This effect was evident for the cognitive assessment 1 h 320 
post MC consumption.  These CBF observations were not associated with any significant modulation 321 
of cognitive performance or mood.   There was also a significant reduction in SBP for up to three 322 
hours post MC consumption relative to the placebo.   323 
Compromised cerebral blood flow has been suggested as a key contributor to cognitive function 324 
decline observed with advancing age and in a number of neurodegenerative diseases 
(46)
.  The results 325 
of the current study demonstrate that MC concentrate can modulate aspects of brain function, which 326 
this was evident 1 h post consumption.  Total-Hb and oxy-Hb were increased toward the end of the 327 
60-min resting/absorption period, although not significantly in most cases, and during the cognitive 328 
assessment 1 h post consumption.  However, there were no concomitant changes in deoxy-Hb across 329 
any of the time points.  These results are consistent with previous studies using compounds and whole 330 
foods to demonstrate a positive effect on cognitive function and CBF.   Kennedy and colleagues 
(30)
 331 
demonstrated an increase in total-Hb and oxy-Hb following single doses of orally administered 332 
resveratrol and more recently, Wightman et al. 
(31)
 following beetroot juice ingestion.  In both of these 333 
studies, total-Hb was increased during the first epoch of task performance.  However, whilst total-Hb 334 
remained higher in the resveratrol study throughout the 40 minute cognitive assessment, it was 335 
decreased during the last 5 repetitions when participants were supplemented with beetroot juice.  In 336 
the current study, no significant differences were seen following the first task period.  The limitations 337 
associated with NIRS have consistently been highlighted 
(47)
, and in the past few years, fMRI and 338 
other neuroimaging techniques have been used to assess the effect of a nutritional supplement on CBF 339 
(33; 48)
. 340 
In terms of higher total-Hb concentrations, the modulation seen in the current study may be due to the 341 
vasorelaxatory and antihypertensive properties of some of the phenolic acids (vanillic and 342 
protocatechuic acid) contained in the MC concentrate 
(3; 10)
. The time points (~1 hour post) at which 343 
these metabolites are seen in the plasma coincide with improvements in vascular function 
(10)
, and 344 
modulation in CBF in the current study.  Although, deoxy-Hb was not modulated by the experimental 345 
beverage, it should be noted that there was a trend for a reduced concentration throughout the task 346 
period. Furthermore, in the current study, task had no significant effect on cerebral modulation.  It has 347 
previously been speculated that “high activation” tasks such as RVIP result in a higher increase in 348 
CBF than does performance in “low activation” tasks, for example digit vigilance.  This can be 349 
largely attributed to the relative cognitive demands of the two tasks, with RVIP requiring the 350 
monitoring of rapidly changing digits along with a passive contribution from working memory.  We 351 
speculate that these very early on effects on CBF in the current study are more likely to be associated 352 
with the sensory properties of the MC concentrate as previous studies have showed demonstrated that 353 
a number of sensory factors including differing taste and flavours are likely to modulate frontal cortex 354 
activity 
(49; 50)
.  Marciani and colleagues previously demonstrated that several brain areas were 355 
activated immediately after swallowing particularly when supplements had a strong (combined) taste 356 
or aroma.  It could be argued that the MC concentrate was more sensory stimulating than the placebo.  357 
However, a full analysis of sensory properties was outside the remit of the current study. 358 
Although the current study highlights an acute heightened NIRS response in brain regions responsible 359 
for task performance, there no was effect on cognitive performance.  Supplementary oxygen 
(51)
 has 360 
been shown to positively influence cognitive performance in a healthy population.  Therefore, it 361 
makes the expectation tenable that increases in CBF could be beneficial to acute cognitive 362 
performance via increasing the delivery of oxygenated blood metabolic substrate to, and efflux of 363 
metabolites from the brain, which is critical for brain function 
(52)
.  Importantly, despite some 364 
indication of improved blood flow, the current study showed no changes in cognitive task 365 
performance between experimental conditions. Nevertheless, these results do not stand alone; 366 
Caldwell et al. 
(24)
 previously demonstrated that regardless of dose, cherry juice had no acute impact 367 
on cognitive function in young people, older people or dementia patients.  They concluded that 368 
although cherry juice may have an acute impact on cardiovascular function, there was no change in 369 
cognitive performance 6 h post consumption. However, Caldwell and colleagues used sweet cherries 370 
as an intervention, it has been speculated that sweet cherries are not as rich in phytochemical 371 
compounds as tart/sour cherries 
(6)
.  Furthermore, cognitive assessments and blood flow measures 372 
were taken at baseline, 2 and 6 h post consumption, the current study attempted to explore the time 373 
points following consumption in more detail (hourly), however it is possible that any potential 374 
changes might still have been missed. Contrastingly, a chronic study by the same group 
(25)
 reported 375 
that the daily consumption of sweet cherries for 12 weeks improved cognitive performance across 376 
almost all tasks in older adults with mild-to-moderate dementia; this group showed improvements for 377 
category verbal fluency and tasks relating to verbal learning and memory and concluded the positive 378 
changes have clinical relevance for these cognitive improvements.  Therefore, it is likely that 379 
regulation of blood flow and cognition are extremely complex, with multiple overlapping regulatory 380 
mechanisms paradigms and contributing structural components 
(53)
, and therefore more likely to be 381 
influenced by chronic supplementation.  This also accords with previous observations in similar trials, 382 
where Kelly et al. 
(54)
 and Thompson et al. 
(55)
 showed that after acute beetroot supplementation, there 383 
were no changes in cognitive performance for concentration, memory, attention or information 384 
processing ability.  However, when older type 2 diabetics were supplemented with beetroot juice for 385 
14 days, they experienced a significant improvement in simple reaction time compared to a control 386 
group 
(56)
.  These somewhat contrasting results may be partly explained by dose duration.  It would 387 
seem that the cerebrovascular response required to elicit measurable changes in cognitive function can 388 
only be achieved with longer term dosing strategies that have the potential to induce sustained 389 
modifications to cerebrovascular function 
(26)
.  However, contrary to this suggestion, two recent 390 
additions to the literature have demonstrated positive effects on cognitive function following acute 391 
blackcurrant 
(27)
 and wild blueberries (WBB) 
(28)
 supplementation.  Acute blackcurrant 392 
supplementation was shown to improve RVIP accuracy and reaction time on the DV task in healthy 393 
people.  Whilst, Whyte and colleagues demonstrated that acute cognitive benefits can be observed in 394 
7-10-year old-children with an anthocyanin-rich blueberry intervention. The Page’s test revealed the 395 
consistency and strength of this finding with WBB supplementation leading to significant overall 396 
improvements in cognition function, with the best change from baseline performance associated with 397 
30g WBB treatment, intermediate performance with the 15g WBB treatment, and least effective 398 
performance with the vehicle treatment. Given that the protective cognitive effect of fruits is 399 
attributed to their high anthocyanin content, the anthocyanin dose in both of these studies was 400 
marginally higher than the current investigation (253 mg and 552 mg vs. 68 mg cyanidin-3-glucoside 401 
/L), this might go some way in explaining the inconsistent findings. It is also worthy to note, the 402 
cognitive tasks in the current study were selected on the basis of previous sensitivity to nutritional 403 
interventions 
(18; 27)
, however, these tasks may not be adequately sensitive to detect change in acute 404 
studies as perhaps this particular intervention could affect different cognitive domains (i.e. memory, 405 
recall).  The most important consideration in setting up a suitable framework for measuring human 406 
cognitive function in polyphenol or flavonoid research is to determine methods that are sensitive to 407 
dietary changes and repeatable over time, simple to interpret and specific to cognitive domains 
(57)
. 408 
Furthermore, all participants in the current study were healthy with no apparent issues pertaining to 409 
cerebral blood flow or cognitive ability. It is logical to question if that could mean that sufficient 410 
blood flow already exist for maximal cognitive performance and therefore, increasing blood flow 411 
beyond this threshold does not have any acute benefits on cognitive performance.   412 
Additionally, there was no effect of the intervention on mood. This is somewhat surprising as mental 413 
fatigue has been previously shown to be receptive to cocoa flavanols in healthy adults 
(18)
.  However, 414 
Scholey and colleagues employed repeated 10-min cycles of a Cognitive Demand Battery (two serial 415 
subtraction tasks [Serial Threes and Serial Sevens] and RVIP), over the course of 1 h.  Therefore, the 416 
cognitive assessment adopted in the current study might not have been as taxing on the brain as the 417 
aforementioned CDB with very limited rest time between repetitions.  418 
There was a significant decrease in systolic blood pressure following MC supplementation when 419 
compared to placebo.  These findings are in agreement with a previous study that reported a positive 420 
modulation of SBP in early hypertensive males following MC ingestion 
(10)
. This is not surprising, as 421 
participants in the current study had moderately elevated systolic blood pressure above the published 422 
ideal values at baseline - 128/82 mmHg.  Kapil et al. 
(58)
 noted that the magnitude of change in the BP 423 
response is directly related to baseline BP therefore, those who have a higher BP, will likely 424 
experience a greater change following an intervention.  The current study is particularly noteworthy as 425 
data from prospective, observational studies have shown a reduction in mean SBP of 5-6 mmHg over 426 
a five year period was associated with 38% and 23% reduced risk of stroke and coronary heart 427 
disease, respectively 
(59)
. Here, we reported peak reductions in postprandial SBP of 6 ± 2 mmHg 428 
relative to the placebo. This finding, along with the modulation of CBF 1 h post MC consumption 429 
supports the growing body of evidence showing an inverse association between the risk of chronic 430 
human diseases and the consumption of polyphenolic rich diet 
(60; 61)
. 431 
The findings of the current study should be interpreted with a certain degree of caution because of the 432 
dietary restrictions imposed on participants.  It is extremely unlikely that one would consume a diet 433 
that is free from polyphenol-rich foods and as a result, future work should attempt to demonstrate 434 
synergistic effects of MC supplementation within habitual dietary practices.  Furthermore, a digital 435 
automatic BP monitor was used in the current study.   The accuracy of this method has been called 436 
into question 
(62)
.  Future studies should consider using ambulatory blood pressure measurements, 437 
where readings are taking at regular intervals.  Many studies have now confirmed that blood pressure 438 
measured over a 24-hour period is superior to clinic blood pressure in predicting future cardiovascular 439 
events 
(63)
.   A timeframe of 5 h was utilized based on previous findings that phenolic compounds are 440 
quickly absorbed and/or excreted 
(3; 36)
 and that any positive effects in vascular function are transient 441 
and return to baseline after four hours 
(10)
.   However, it is possible that this timeframe may not long 442 
enough to capture the absorption of potentially other bioactive phenolic compounds provided by 443 
cherries in the colon. 444 
In summary, the findings from this study suggest that MC concentrate can acutely modulate CBF in 445 
the prefrontal cortex characterized by increased concentrations of both total-Hb and oxy-Hb.  Despite 446 
this evident modulation, these results do not translate to improvements in cognition or mood in the 447 
hours following consumption.    Finally, this study reaffirms previous findings that demonstrate a 448 
significant improvement in SBP following MC supplementation.   449 
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 Table 1. Effects of MC concentrate and PLA on various aspects of cognitive performance in healthy, middle aged adults.  
  Task battery repetition   
  Baseline 
 
1 
 
2 
 
3 
 
5 
 
ANOVA 
 
Measures Treatment  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Effect F P 
DV (%) 60 mL MC 94.20 1.11 94.30 1.40 93.58 1.38 92.29 1.67 92.28 2.00 T 0.087 0.771 
Placebo 95.17 0.88 94.47 1.16 94.08 1.33 92.59 1.78 92.10 2.02 T × R 0.137 0.890 
DV RT (ms) 60 mL MC 455.41 8.08 461.85 8.99 464.01 8.01 472.10 8.93 470.05 9.35 T 3.793 0.062 
Placebo 455.48 8.19 461.02 8.58 465.76 9.10 454.59 11.06 443.96 16.15 T × R 2.109 0.135 
RVIP (%) 60 mL MC 53.40 5.04 52.85 4.23 51.24 5.08 51.70 4.98 52.31 4.80 T 0.027 0.870 
Placebo 51.69 4.30 55.12 4.67 51.34 4.87 53.47 4.47 52.15 4.73 T × R 0.391 0.759 
RVIP RT(ms) 60 mL MC 491.55 32.22 517.05 12.13 522.39 10.99 527.96 10.99 504.35 11.81 T 0.269 0.608 
Placebo 526.14 11.55 520.01 12.02 483.81 29.07 505.52 17.11 506.96 15.74 T × R 1.145 0.316 
Stroop (%) 60 mL MC 98.65 0.24 98.78 0.26 98.69 0.24 98.77 0.23 98.62 0.25 T 0.960 0.414 
Placebo 98.58 0.24 98.65 0.30 98.89 0.24 99.01 0.20 98.96 0.21 T × R 0.667 0.298 
Stroop RT (ms) 60 mL MC 789.04 30.74 774.62 26.85 778.11 36.00 753.95 26.71 761.07 24.48 T 0.214 0.648 
Placebo 814.87 37.53 764.02 29.23 764.00 29.23 763.36 29.75 805.29 68.20 T × R 0.677 0.487 
All values are means ± SEM (n=27) T, treatment; R, repetition; DV, digit vigilance; RVIP, rapid visual information processing; RT, reaction time. 
 
 
 
 
 
 
 
 Table 2.  Effects of MC concentrate and PLA on mood in healthy, middle aged subjects.  
  Task battery repetition   
  Baseline 
 
1 
 
2 
 
3 
 
5 
 
ANOVA 
 
Measures Treatment  Mean SEM Mean SEM Mean SEM Mean SEM Mean SEM Effect F P 
Alert 60 mL MC 35.67 4.55 35.39 3.55 40.31 4.11 42.91 4.41 45.22 4.44 T 0.415 0.525 
Placebo 35.10 3.91 34.76 3.49 43.13 3.70 45.30 3.94 49.85 4.37 T × R 0.763 0.477 
Concentration 60 mL MC 57.19 4.83 52.50 3.68 52.39 3.69 50.94 3.49 47.96 3.42 T 0.287 0.597 
Placebo 51.75 3.61 57.02 3.19 48.80 3.44 49.15 3.50 46.93 3.52 T × R 1.417 0.250 
Mental fatigue 60 mL MC 60.74 4.29 61.54 3.76 60.94 4.13 58.69 3.97 57.20 4.21 T 0.163 0.690 
Placebo 61.65 3.95 63.44 3.32 55.76 3.82 54.30 4.09 56.85 4.08 T × R 1.281 0.288 
Difficulty  60 mL MC 38.41 3.91 38.94 3.46 40.50 4.21 41.57 4.21 44.59 3.81 T 0.014 0.907 
Placebo 40.73 3.69 36.65 3.41 39.78 3.08 38.96 3.43 44.96 3.50 T × R 0.631 0.579 
All values are means ± SEM (n=27) T, treatment; R, repetition. 
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Figure 1: Time course of systolic blood pressure (mean ± SEM) response after consumption of MC 
concentrate- and macronutrient – matched control (n=27).  Significantly different from the placebo 
drink: * p < 0.05  
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Figure 2: A:  Mean (± SEM) changes in concentrations of oxy-haemoglobin and B: total 
haemoglobin during a 60-min absorption period and subsequent cognitive task assessments 1, 2, 3 and 
5 h post 60mL MC concentrate or placebo.  Significantly different from the placebo: * p < 0.05, ** p 
< 0.01.  
 
